Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 2
1977 3
1979 1
1980 1
1982 1
1983 2
1984 1
1994 1
1995 1
1996 1
1997 2
1998 1
1999 1
2001 8
2002 4
2003 6
2004 2
2005 4
2006 1
2007 4
2008 6
2009 1
2010 2
2011 1
2012 2
2013 2
2014 1
2015 1
2016 1
2017 3
2018 6
2019 4
2021 3
2022 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

78 results

Results by year

Filters applied: . Clear all
Page 1
Platinum-based chemotherapy plus cetuximab in head and neck cancer.
Vermorken JB, Mesia R, Rivera F, Remenar E, Kawecki A, Rottey S, Erfan J, Zabolotnyy D, Kienzer HR, Cupissol D, Peyrade F, Benasso M, Vynnychenko I, De Raucourt D, Bokemeyer C, Schueler A, Amellal N, Hitt R. Vermorken JB, et al. Among authors: remenar e. N Engl J Med. 2008 Sep 11;359(11):1116-27. doi: 10.1056/NEJMoa0802656. N Engl J Med. 2008. PMID: 18784101 Free article. Clinical Trial.
Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer.
Vermorken JB, Remenar E, van Herpen C, Gorlia T, Mesia R, Degardin M, Stewart JS, Jelic S, Betka J, Preiss JH, van den Weyngaert D, Awada A, Cupissol D, Kienzer HR, Rey A, Desaunois I, Bernier J, Lefebvre JL; EORTC 24971/TAX 323 Study Group. Vermorken JB, et al. Among authors: remenar e. N Engl J Med. 2007 Oct 25;357(17):1695-704. doi: 10.1056/NEJMoa071028. N Engl J Med. 2007. PMID: 17960012 Free article. Clinical Trial.
Progression of head and neck squamous cell cancer.
Tímár J, Csuka O, Remenár E, Répássy G, Kásler M. Tímár J, et al. Among authors: remenar e. Cancer Metastasis Rev. 2005 Jan;24(1):107-27. doi: 10.1007/s10555-005-5051-5. Cancer Metastasis Rev. 2005. PMID: 15785876 Review.
Malignant mucosal melanoma of the head and neck.
Lengyel E, Gilde K, Remenár E, Esik O. Lengyel E, et al. Among authors: remenar e. Pathol Oncol Res. 2003;9(1):7-12. doi: 10.1007/BF03033707. Epub 2003 Apr 18. Pathol Oncol Res. 2003. PMID: 12704440 Free article. Review.
[Consequences of extracellular alterations of EGFR on cetuximab therapy in HNSCC].
Cserepes M, Nelhűbel GA, Meilinger-Dobra M, Surguta SE, Rásó E, Ladányi A, Kenessey I, Szöőr Á, Vereb G, Remenár É, Tóvári J. Cserepes M, et al. Among authors: remenar e. Magy Onkol. 2021 Jun 3;65(2):188-195. Epub 2021 May 12. Magy Onkol. 2021. PMID: 34081766 Free article. Hungarian.
EGFR R521K Polymorphism Is Not a Major Determinant of Clinical Cetuximab Resistance in Head and Neck Cancer.
Cserepes M, Nelhűbel GA, Meilinger-Dobra M, Herczeg A, Türk D, Hegedűs Z, Svajda L, Rásó E, Ladányi A, Csikó KG, Kenessey I, Szöőr Á, Vereb G, Remenár É, Tóvári J. Cserepes M, et al. Among authors: remenar e. Cancers (Basel). 2022 May 13;14(10):2407. doi: 10.3390/cancers14102407. Cancers (Basel). 2022. PMID: 35626010 Free PMC article.
78 results